Drug Approval | July 31, 2023
The product basket increased to 1800 medicines and 285 Surgical Equipment
In March 2023, Japan’s Ministry of Health and Labor Welfare approved Novo Nordisk’s once-weekly subcutaneous glucagon-like peptide-1
Astec LifeSciences has reported total income of Rs. 144.55 crores during the period ended June 30, 2023
Marks the World Head & Neck Cancer Day at the OCTF Conference
Uses a simple mechanical approach for removing intrauterine tissues
Preclina is renowned for its highly specialized services in autoimmune and inflammatory disorders
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Subscribe To Our Newsletter & Stay Updated
